Opportunities and Challenges of Chatbots in Ophthalmology: A Narrative Review.

Mehmet Cem Sabaner, Rodrigo Anguita, Fares Antaki, Michael Balas, Lars Christian Boberg-Ans, Lorenzo Ferro Desideri, Jakob Grauslund, Michael Stormly Hansen, Oliver Niels Klefter, Ivan Potapenko, Marie Louise Roed Rasmussen, Yousif Subhi
Author Information
  1. Mehmet Cem Sabaner: Department of Ophthalmology, Kastamonu University, Training and Research Hospital, 37150 Kastamonu, Türkiye. ORCID
  2. Rodrigo Anguita: Department of Ophthalmology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland. ORCID
  3. Fares Antaki: Moorfields Eye Hospital National Health Service Foundation Trust, London EC1V 2PD, UK. ORCID
  4. Michael Balas: Department of Ophthalmology & Vision Sciences, University of Toronto, Toronto, ON M5T 2S8, Canada. ORCID
  5. Lars Christian Boberg-Ans: Department of Ophthalmology, Innlandet Hospital Trust, 2382 Brumendal, Norway.
  6. Lorenzo Ferro Desideri: Department of Ophthalmology, Inselspital, University Hospital Bern, University of Bern, 3010 Bern, Switzerland.
  7. Jakob Grauslund: Department of Ophthalmology, Odense University Hospital, 5000 Odense, Denmark. ORCID
  8. Michael Stormly Hansen: Department of Ophthalmology, Rigshospitalet, 2100 Copenhagen, Denmark. ORCID
  9. Oliver Niels Klefter: Department of Ophthalmology, Rigshospitalet, 2100 Copenhagen, Denmark. ORCID
  10. Ivan Potapenko: Department of Ophthalmology, Rigshospitalet, 2100 Copenhagen, Denmark. ORCID
  11. Marie Louise Roed Rasmussen: Department of Ophthalmology, Rigshospitalet, 2100 Copenhagen, Denmark. ORCID
  12. Yousif Subhi: Department of Clinical Research, University of Southern Denmark, 5230 Odense, Denmark. ORCID

Abstract

Artificial intelligence (AI) is becoming increasingly influential in ophthalmology, particularly through advancements in machine learning, deep learning, robotics, neural networks, and natural language processing (NLP). Among these, NLP-based chatbots are the most readily accessible and are driven by AI-based large language models (LLMs). These chatbots have facilitated new research avenues and have gained traction in both clinical and surgical applications in ophthalmology. They are also increasingly being utilized in studies on ophthalmology-related exams, particularly those containing multiple-choice questions (MCQs). This narrative review evaluates both the opportunities and the challenges of integrating chatbots into ophthalmology research, with separate assessments of studies involving open- and close-ended questions. While chatbots have demonstrated sufficient accuracy in handling MCQ-based studies, supporting their use in education, additional exam security measures are necessary. The research on open-ended question responses suggests that AI-based LLM chatbots could be applied across nearly all areas of ophthalmology. They have shown promise for addressing patient inquiries, offering medical advice, patient education, supporting triage, facilitating diagnosis and differential diagnosis, and aiding in surgical planning. However, the ethical implications, confidentiality concerns, physician liability, and issues surrounding patient privacy remain pressing challenges. Although AI has demonstrated significant promise in clinical patient care, it is currently most effective as a supportive tool rather than as a replacement for human physicians.

Keywords

References

  1. Ophthalmol Sci. 2024 Aug 23;5(1):100600 [PMID: 39346575]
  2. EBioMedicine. 2023 Sep;95:104770 [PMID: 37625267]
  3. Am J Ophthalmol. 2024 Oct;266:289-299 [PMID: 38823673]
  4. JMIR Form Res. 2024 Nov 19;8:e64844 [PMID: 39561356]
  5. J Cutan Med Surg. 2024 Sep-Oct;28(5):507-508 [PMID: 39056427]
  6. Eur J Ophthalmol. 2024 Aug 7;:11206721241272251 [PMID: 39110014]
  7. Swiss Med Wkly. 2024 Oct 02;154:3547 [PMID: 39465318]
  8. N Engl J Med. 2023 Mar 30;388(13):1233-1239 [PMID: 36988602]
  9. Graefes Arch Clin Exp Ophthalmol. 2024 Sep;262(9):2945-2959 [PMID: 38573349]
  10. Dig Liver Dis. 2024 Aug;56(8):1304-1311 [PMID: 38503659]
  11. Int J Retina Vitreous. 2023 Nov 18;9(1):71 [PMID: 37980501]
  12. Sci Rep. 2024 Aug 14;14(1):18859 [PMID: 39143077]
  13. JAMA Netw Open. 2023 Aug 1;6(8):e2330320 [PMID: 37606922]
  14. Retina. 2024 Jun 1;44(6):954-964 [PMID: 38271674]
  15. Lancet Glob Health. 2021 Feb;9(2):e130-e143 [PMID: 33275950]
  16. Eye (Lond). 2024 Sep;38(13):2530-2535 [PMID: 38615098]
  17. Br J Ophthalmol. 2024 Sep 20;108(10):1371-1378 [PMID: 37923374]
  18. Br J Ophthalmol. 2024 Sep 20;108(10):1354-1361 [PMID: 38719344]
  19. Clin Exp Optom. 2024 Jan 9;:1-9 [PMID: 38194585]
  20. Int Orthop. 2024 Jan;48(1):151-158 [PMID: 37968408]
  21. Front Artif Intell. 2023 Oct 31;6:1237704 [PMID: 38028668]
  22. Eye (Lond). 2024 Nov;38(16):3113-3117 [PMID: 39003430]
  23. JAMA Ophthalmol. 2016 Jul 1;134(7):802-9 [PMID: 27197072]
  24. JAMA Ophthalmol. 2024 Apr 1;142(4):321-326 [PMID: 38421670]
  25. Int J Retina Vitreous. 2024 Sep 26;10(1):67 [PMID: 39327591]
  26. Front Med (Lausanne). 2024 Jul 09;11:1359073 [PMID: 39050528]
  27. Eur J Investig Health Psychol Educ. 2023 Jan 28;13(2):284-305 [PMID: 36826206]
  28. Int J Retina Vitreous. 2024 Sep 11;10(1):63 [PMID: 39261870]
  29. J Med Internet Res. 2024 Jul 25;26:e60807 [PMID: 39052324]
  30. J Pediatr Ophthalmol Strabismus. 2024 Mar-Apr;61(2):86-89 [PMID: 37882183]
  31. Sci Rep. 2023 Oct 29;13(1):18562 [PMID: 37899405]
  32. Life (Basel). 2024 Apr 26;14(5): [PMID: 38792579]
  33. Ophthalmol Sci. 2024 May 23;4(6):100556 [PMID: 39139542]
  34. J Glob Health. 2024 Jun 14;14:04100 [PMID: 38867671]
  35. Cureus. 2024 Apr 14;16(4):e58232 [PMID: 38745784]
  36. Bioengineering (Basel). 2024 Jan 26;11(2): [PMID: 38391606]
  37. JMIR Med Educ. 2023 Sep 4;9:e46482 [PMID: 37665620]
  38. Eye (Lond). 2024 Jan;38(1):4-7 [PMID: 37369764]
  39. Ophthalmic Physiol Opt. 2024 May;44(3):641-671 [PMID: 38404172]
  40. Ophthalmic Plast Reconstr Surg. 2024 Mar-Apr 01;40(2):217-222 [PMID: 37989540]
  41. Graefes Arch Clin Exp Ophthalmol. 2023 Oct;261(10):3041-3043 [PMID: 37129631]
  42. Children (Basel). 2024 Jun 20;11(6): [PMID: 38929329]
  43. Ophthalmol Sci. 2024 Feb 06;4(4):100485 [PMID: 38660460]
  44. J Fr Ophtalmol. 2023 Sep;46(7):706-711 [PMID: 37537126]
  45. J Surg Educ. 2024 Mar;81(3):438-443 [PMID: 38135548]
  46. Cureus. 2024 Mar 23;16(3):e56766 [PMID: 38650824]
  47. Br J Ophthalmol. 2024 Sep 20;108(10):1398-1405 [PMID: 38365427]
  48. Healthcare (Basel). 2023 May 01;11(9): [PMID: 37174840]
  49. Eye (Lond). 2024 Jun;38(8):1412-1417 [PMID: 38355668]
  50. Br J Ophthalmol. 2024 Sep 20;108(10):1379-1383 [PMID: 37932006]
  51. J Med Internet Res. 2023 Nov 28;25:e47551 [PMID: 38015597]
  52. Ophthalmology. 2014 Nov;121(11):2081-90 [PMID: 24974815]
  53. Am J Ophthalmol. 2023 Oct;254:141-149 [PMID: 37339728]
  54. Lancet Glob Health. 2014 Feb;2(2):e106-16 [PMID: 25104651]
  55. Br J Ophthalmol. 2020 Apr;104(4):588-592 [PMID: 31266774]
  56. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2345-2352 [PMID: 38183467]
  57. Eye (Lond). 2024 Jul;38(10):1897-1902 [PMID: 38509182]
  58. Acad Med. 2018 Aug;93(8):1107-1109 [PMID: 29095704]
  59. Br J Ophthalmol. 2024 Sep 20;108(10):1457-1469 [PMID: 38448201]
  60. JMIR Med Educ. 2024 Jan 16;10:e49970 [PMID: 38227351]
  61. Can J Ophthalmol. 2024 Aug 1;: [PMID: 39097289]
  62. Medicine (Baltimore). 2023 Aug 11;102(32):e34673 [PMID: 37565917]
  63. Ocul Immunol Inflamm. 2024 Oct;32(8):1526-1531 [PMID: 37722842]
  64. J Pers Med. 2024 Aug 19;14(8): [PMID: 39202068]
  65. Cureus. 2023 Jun 24;15(6):e40895 [PMID: 37492832]
  66. Heliyon. 2024 Jan 08;10(2):e24289 [PMID: 38298626]
  67. Semin Ophthalmol. 2024 Aug;39(6):472-479 [PMID: 38516983]
  68. PLOS Digit Health. 2024 Feb 14;3(2):e0000349 [PMID: 38354127]
  69. Cureus. 2024 Mar 31;16(3):e57348 [PMID: 38690460]
  70. J Endourol. 2024 Nov;38(11):1172-1177 [PMID: 39212674]
  71. PLOS Digit Health. 2023 Feb 9;2(2):e0000198 [PMID: 36812645]
  72. Lancet Glob Health. 2021 Feb;9(2):e144-e160 [PMID: 33275949]
  73. BMJ Glob Health. 2023 May;8(5): [PMID: 37160371]
  74. Cureus. 2023 Jun 22;15(6):e40822 [PMID: 37485215]
  75. Eye (Lond). 2024 Mar;38(4):809-810 [PMID: 37726334]
  76. PLoS One. 2023 Aug 29;18(8):e0290691 [PMID: 37643186]
  77. Acta Ophthalmol. 2023 Nov;101(7):829-831 [PMID: 36912780]
  78. Clin Orthop Surg. 2024 Aug;16(4):669-673 [PMID: 39092297]
  79. Med Educ Online. 2023 Dec;28(1):2182659 [PMID: 36855245]
  80. Ophthalmol Sci. 2023 May 05;3(4):100324 [PMID: 37334036]
  81. Ophthalmol Retina. 2023 Oct;7(10):862-868 [PMID: 37277096]
  82. Asia Pac J Ophthalmol (Phila). 2024 Jul-Aug;13(4):100085 [PMID: 39059558]
  83. JAMA Ophthalmol. 2023 Jun 1;141(6):589-597 [PMID: 37103928]
  84. JMIR Med Educ. 2024 Jan 18;10:e50842 [PMID: 38236632]
  85. J Med Syst. 2024 Feb 17;48(1):22 [PMID: 38366043]
  86. Cureus. 2024 Jan 18;16(1):e52485 [PMID: 38371109]
  87. Can J Ophthalmol. 2024 Aug;59(4):e301-e308 [PMID: 37572695]
  88. Cureus. 2023 Dec 4;15(12):e49903 [PMID: 38174202]

Word Cloud

Created with Highcharts 10.0.0ophthalmologychatbotspatientlanguageresearchstudiesintelligenceAIincreasinglyparticularlylearningAI-basedlargeclinicalsurgicalquestionschallengesdemonstratedsupportingeducationpromisediagnosisArtificialbecominginfluentialadvancementsmachinedeeproboticsneuralnetworksnaturalprocessingNLPAmongNLP-basedreadilyaccessibledrivenmodelsLLMsfacilitatednewavenuesgainedtractionapplicationsalsoutilizedophthalmology-relatedexamscontainingmultiple-choiceMCQsnarrativereviewevaluatesopportunitiesintegratingseparateassessmentsinvolvingopen-close-endedsufficientaccuracyhandlingMCQ-baseduseadditionalexamsecuritymeasuresnecessaryopen-endedquestionresponsessuggestsLLMappliedacrossnearlyareasshownaddressinginquiriesofferingmedicaladvicetriagefacilitatingdifferentialaidingplanningHoweverethicalimplicationsconfidentialityconcernsphysicianliabilityissuessurroundingprivacyremainpressingAlthoughsignificantcarecurrentlyeffectivesupportivetoolratherreplacementhumanphysiciansOpportunitiesChallengesChatbotsOphthalmology:NarrativeReviewBardBingChatGPTClaudeGeminiartificiale-learningmodel

Similar Articles

Cited By